KAZIA THERAPEUTICS Trademark
KAZIA THERAPEUTICS is a USPTO trademark filed by Kazia Therapeutics Limited. Status: Registered.
Trademark Facts
| Mark | KAZIA THERAPEUTICS |
|---|---|
| Serial Number | 79227049 |
| Registration Number | 5640030 |
| Status | Registered |
| Filing Date | 2017-09-26 |
| Registration Date | 2019-01-01 |
| Mark Type | Word |
| Nice Classes | 001 (Chemicals), 005 (Pharmaceuticals), 042 (Software & IT) |
| Owner | Kazia Therapeutics Limited |
| Attorney of Record | Sana Hakim |
| Prosecution Events | 42 |
| Latest Event | NA71 on 2025-09-09 |
Goods & Services
Pharmaceutical preparations, namely, cytotoxic chemotherapy; pharmaceutical preparations for the treatment of cancer; anti-cancer pharmaceutical preparations; pharmaceutical preparations for the diagnosis and treatment of cancer; medicines for human use, namely, pharmaceutical compounds for treating cancer; pharmaceutical preparations for treating chemical imbalances; diagnostic preparations for medical purposes; Chemicals used in science; chemical products for use in the manufacture of pharmaceuticals and medicine; biochemicals, namely, precursors for in vitro genetic engineering use in the field of pharmaceuticals and medicine; chemical preparations for the manufacture of pharmaceuticals; chemicals for use in manufacturing of pharmaceuticals; "THERAPEUTICS"; Scientific research services; scientific and medical research services; pharmaceutical research services; research relating to pharmaceuticals; research and development of pharmaceuticals; biotechnology research; biochemical and chemical research services; scientific research relating to biology and chemistry; scientific research in the field of pharmacy; scientific research into the development of new products; services for assessing the safety of pharmaceuticals, namely, scientific laboratory services for assessing efficacy of pharmaceuticals; scientific research services featuring the preparation of reports thereon; medical analytical laboratory services; laboratory research and analysis in the field of pharmaceuticals; laboratory research and analysis in the field of cancer treatments; development of products; development of new products; development of pharmaceutical preparations for the diagnosis and treatment of cancer; advisory services relating to scientific research; consultancy and information services relating to the aforementioned services